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Abstract. The problem of variable cell survival probability along the spread-out Bragg peak is one of the
long standing problems in planning and optimisation of ion-beam therapy. This problem is considered
using the multiscale approach to the physics of ion-beam therapy. The physical reasons for this problem
are analysed and understood on a quantitative level. A recipe of solution to this problem is suggested using
this approach. This recipe can be used in the design of a novel treatment planning and optimisation based
on fundamental science.
PACS. XX.XX.XX No PACS code given
The ion-beam cancer therapy has been developed in
the 1990s as a hopeful improvement of a conventional radi-
ation therapy with x-rays. The possibility of employment
of a physical behaviour of ionization cross section of ions
at decreasing energies giving rise to the Bragg peak in the
depth-dose curve for better focusing the locus of radiation
damage and sparing healthy tissues is the main attraction
of this endeavour [1,2,3,4,5,6,7,8]. Proton-beam therapy
is the most proliferated type of ion-beam therapy, and this
paper is more linked with protons, however, the results can
be easily extended to include heavier ions.
When proton-beam therapy is used, a beam comprised
of protons of a given energy enters a patient’s tissue. Typi-
cal initial energies are in the range of 70-230 MeV. Having
entered the tissue, protons gradually slow down until their
energy is above ∼ 1 MeV; at a high speed the probability
of interaction with the medium is small and the depth-
dose curve exhibits a plateau. When protons energy drops
below 1 MeV (1 MeV/u for heavier ions), this probabil-
ity (related to the cross section of inelastic collisions with
molecules of tissue) increases rapidly. As a result projec-
tiles lose most of their remaining energy within a short
length segment referred to as the pristine Bragg peak. The
position of the pristine Bragg peak for a given medium
(such as tissue) and type of ions solely depends on their
initial energy. Then, tuning the initial energy so that the
position of the Bragg peak overlaps with a tumour loca-
tion seems to be the next logical step. However, typical
tumour sizes exceed the 1-mm size of the Bragg peak by
at least an order of magnitude. Then one have to scan the
tumour with beams of different energies; this creates an-
Send offprint requests to: Eugene Surdutovich
other phenomenon, the spread-out Bragg peak (SOBP).
Images of pristine and spread out Bragg peaks are shown
in Fig. 1.
Radiation oncologists or medical physicists involved in
planning and optimization of irradiation of patients base
their protocols on a relation of a necessary dose to be de-
livered to a given voxel to the desired probability of cell
survival in that volume. The dependence of this probabil-
ity on dose is determined by the so-called survival curves.
In general, the survival curves depend on the type of pro-
jectiles, type of cells, phase of cells in their cycle, degree of
oxygenation, and other possible conditions [7]. In the case
of x-ray radiation, the only radiation parameter that de-
scribes the irradiation of a voxel is the dose, even though
the mechanisms of radiation damage are rather complex.
The target dose for treatment planning can be determined
given the experimentally known survival curve for given
cells and conditions [7,9].
In the case of irradiation with ions, there are at least
two major issues. They originate from the fact that the
dose, which physically corresponds to energy, loses its uni-
queness in predicting biodamage. It becomes inevitable to
address the fact that the damage is not done by energy; in-
stead, it is due to physical and chemical processes caused
by agents such as electrons ejected by ions, free radicals
(also formed as a result of the action of ions), other reac-
tive species, and possibly other physical effects. This is
reflected in the introduction of such macroscopic parame-
ters as relative biological effectiveness (RBE) and oxygen
enhancement ratio(OER). The abundance and spatial dis-
tribution of the above reactive species depend on dose and
linear energy transfer (LET), the medium, etc., but this
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dependence is not trivial; the understanding of radiation
biodamage on a fundamental level is necessary in order to
establish this dependence and bring therapy optimisation
and planning to a higher scientific level.
The radiation quality, a term related to the value of
LET, of the delivered dose depends on the position along
the SOBP. The cell survival depends on both the dose
and the LET. The distal end is irradiated with protons
at their pristine Bragg peak while the proximal end is
irradiated with a superposition of protons with different
values of LET; only a few of them are at the Bragg peak
energies. This introduces a difference between the quality
of different parts of the SOBP leading to different values
of both relative biological effectiveness (RBE) and oxygen
enhancement ratio (OER). The existence of this problem
has been recognised a long time ago and there have many
studies devoted to this. A thorough experimental analysis
has been done and discussed, e.g., in ref. [10].
The currently accepted model for relating the dose
with cell survival probability for ions is the local effect
model (LEM) [11,4,12,13]), which associates the dose de-
livered to a voxel calculated probabilistically with the prob-
ability of cell survival taken from x-ray survival curves.
This model only accounts for the effects of dose deposited
in cell nuclei without analyzing physical, chemical or bi-
ological effects. Although this model claims predictive re-
sults on the basis of well known x-ray survival curves, there
are serious doubts that these survival curves are relevant
in the case of ions [14,15]. More recent versions of LEM
model are available[16,17], but they account for quality
only empirically, again tailoring the radiation quality ef-
fects with x-ray curves. On top of this, there is no solid
scientific assessment of radiation damage inside the SOBP,
since the cell survival depends on LET and, hence, on the
position in the SOBP [10]. In this paper we will argue that
the lack of understanding of this dependence on LET is
the main reason for the problem of varying cell survival
along the SOBP has not yet been solved [18]. This topic
is discussed at numerous conferences, such as Radiation
Research Society (RRS), Application of Accelerators in
Research and Industry (CAARI), Particle Therapy Co-
operative Group (PTCOG), to name a few.
The problem of varying cell survival along the SOBP
is vexing for proton-beam therapy and it is important to
solve it. In this paper, we present a recipe of solution
to this problem using the developed multiscale approach
(MSA) to the physics of radiation damage with ions [19,
15]. The MSA relies directly on the physical, chemical,
and biological effects that underlie the observed biological
damage. In this approach, a target cell nucleus is irradi-
ated with ions having different LET. Then the average
number of lethal lesions per cell is calculated taking into
account the LET, cell properties, and external conditions
such as degree of oxygenation. This way, the dose and the
radiation quality are directly associated with a predicted
radiation damage. The predictability of cell survival by
the MSA has been successfully tested on a variety of cell
lines with different values of LET and oxygenation condi-
tions [20]. It is tempting to use the technique vindicated
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Fig. 1. The dependence of LET for protons as a function of
distance from the distal side of depth-dose curve. The dashed
line shown a pristine Bragg peak calculated for protons with
an initial energy of 200 MeV. The solid line shows a SOBP
obtained as a superposition of proton beams of initial ener-
gies from 194.5 to 200 MeV with fluences chosen so that the
physical dose profile along the SOBP is uniform.
by that work to develop an algorithm of obtaining a flat
profile for the cell survival along the SOBP.
The goal of this work is to develop such an algorithm,
but in order to reach this goal, we first need to calculate
the survival probability at an arbitrary position within the
SOBP. After this is achieved, we will calculate the profile
of cell survival probability along the SOBP for a uniform
profile of physical dose. Then, the profile of physical dose
that makes the cell survival probability along the SOBP
uniform will be found.
In Refs. [15,20] the cell survival probabilities were cal-
culated as function of dose, LET, and oxygen concentra-
tion. A clustered DNA lesion is defined as the number of
DNA lesions, such as DSBs, SSBs, abasic sites, damaged
bases, etc., that occur within about two helical turns of a
DNA molecule so that, when repair mechanisms are en-
gaged, they treat a cluster of several of these lesions as
a single damage site [21,22,23,24,25,26,27]. In ref. [15],
a criterion for lethality of damage was suggested and im-
plemented for the calculation of survival curves. This cri-
terion is based on the idea that among different DNA le-
sions caused by interaction with reactive species the mul-
tiply damaged sites with a sufficient complexity may not
be repaired (this followed Ref.[28]). Namely, it was postu-
lated [15] that a lesion consisting of a DSB and at least two
other simple lesions such as SSB within two DNA twists
is lethal. Then in Ref. [20] this criterion was applied and
justified for a number of cell types.
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The first step after the justification of the criterion of
lethality is to calculate the number of lethal damage sites,
produced by an ion (with a given energy and, hence, LET)
per length of a segment of its trajectory, dNl
dx
(where dx is a
length of this segment) [15]. That calculation relies on the
transport of reacting species that included a collective flow
due to the shock waves around ions’ paths predicted by
the MSA [29,15]. The strength of shock waves and radius
of propagation of reactive species depend on the LET. The
collective transport of radicals by shock waves has been
most recently demonstrated by MD simulations [30]; for
these simulations, the MBN Explorer with reactive force-
field [31,32] has been employed. In principle, the value of
dNl
dx
can be studied experimentally by the analysis of repair
foci [33] and we hope that a more thorough comparison
with experimental results will be done, but this is only a
side issue for this work.
The value of dNl
dx
is proportional to the number den-
sity of chromatin, ns, and cross section of lethal damage
σl(Se),
dNl
dx
= nsσl(Se) . (1)
This cross section is discussed in much detail in Refs. [15,
20], where it is derived along with the criterion of lethal-
ity. The main idea of its derivation is briefly outlined in
the appendix. Strictly speaking, besides LET (so-called re-
stricted LET, Se, that excludes nuclear fragmentation ef-
fects), σl(Se) depends on the concentration of oxygen [20].
The oxygen concentration influences the effectiveness of
reactive species. In this work, we assume that this con-
centration does not vary along the SOBP, but in principle
it may and this can be included in the method suggested
below. Then the average yield of lethal DNA lesions in the
cell nucleus is given by the product of dNl
dx
in (1) and the
average length of traverse of all ions passing through a cell
nucleus for a given dose [15,20],
Yl =
dNl
dx
z¯ Nion(d), (2)
where the length of traverse is presented by a product of
average length of traverse by a single ion z¯ and the number
of ions that pass through the cell nucleus Nion. The latter
depends on dose d as
Nion = An d/Se , (3)
where An is the cross sectional area of the cell nucleus.
Equations (2) and (3) can be combined:
Yl =
dNl
dx
z¯ Nion(d) =
pi
16
σl(Se)Ng
d
Se
=
pi
16
σl(Se)Ng
Nion
An
=
pi
16
σl(Se)NgF , (4)
where Ng is the genome size, i.e., a constant number and
Nion
An
= F is the ions’ fluence in the beam.
Since the probability of cell inactivation is obtained
by subtracting the probability of zero lethal lesions occur-
rence from unity, (1 − exp [−Yl]) and that of cell survival
is given by unity less the probability of cell inactivation,
the logarithm of cell survival probability is simply given
by Eq. (4) with a negative sign, i.e.,
lnΠsurv = −Yl = −
pi
16
σl(Se)NgF . (5)
This formula, verified in Ref. [20], is remarkable: it sug-
gests that cell survival at a given place depends only on
LET, oxygen concentration (both contained in σl(Se)),
and the ions’ fluence.
If the Bragg peak is not pristine, Eq. (3) has to be
modified, because the ion’s fluence is not a number any
more, but rather a superposition of fluences of ions with
different energies.
Instead there will be a superposition of numbers of
ions traversing a cell nucleus at a different energies with
different LET. Equation (5) will change as well:
lnΠsurv = −
pi
16
Ng
∑
j
σl(Sj)Fj , (6)
where index j corresponds to a given fraction of ion’s flu-
ence corresponding to a certain energy and LET within a
SOBP.
In order to reproduce the problem with nonuniform
survival probability along the SOBP, we need to construct
the SOBP, i.e., find such a linear combination,
∑
j fjF
(where fj are coefficients corresponding to ions with initial
kinetic energy E0,j), that will produce a uniform dose dis-
tribution along the SOBP. In order to do this, the depth-
dose curve for protons (in this case) has to be known.
There are many more or less sophisticated ways to ob-
tain these curves, e.g., based on Monte Carlo simulations
of ions’ transport [34,35]. However, this work is method-
ological, and we use a calculation scheme [36,37,15], where
the shape of a Bragg peak including energy straggling
and charge transfer has derived from a semi-empirical
model [38]. The result is the dose-depth distribution for a
pristine Bragg peak. Then stepping down in protons ini-
tial energy by 0.5 MeV, we can calculate what fraction of
a beam of this energy is needed in order to achieve a uni-
form dose distribution. This procedure lasts through the
full length of the SOBP.
The dose at a given depth x is proportional to the net
LET:
Se(x) =
∑
j
fjSj(x)dx = S0 , (7)
where S0 is a constant. The stopping power at a distal
side of the SOBP is equal to the S(Emax), therefore S0 =
S(Emax). We can start the construction from the distal
side:
Se(x0) = S0(E0, x0)
Se(x1) = S0(E0, x1) + f1S1(E0 −∆E, x1)
Se(x2) = S0(E0, x2) + f1S1(E0 −∆E, x2)
+f2S2(E0 − 2∆E, x2)
...
Se(xN ) =
∑
fjSj(E0 −N∆E, xN ) , (8)
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Fig. 2. The solid line shows the profile of dependence of
yield of lethal lesions in cells along the SOBP as a function of
distance on the distal end of the SOBP. The dashed line shows
the profile of the depth-dose curve that produced the above
result. The algorithm (8) has been used.
where xj is the coordinate of the Bragg peak correspond-
ing to initial energy E0,j = E0 − j∆E For each j, the
coefficient fj is determined from equation j. The length
of the SOBP, xp, is equal to the difference x0 − xN . This
condition determines N . The example of such a construc-
tion is given in Fig. 1, where the SOBP is constructed for
xp = 12 mm with ∆E = 0.5 MeV (this number is used in
current clinical protocols).
Then, the value of σl(Sj) can be calculated using the
parameters employed in Ref. [20]. The results for survival
probabilities calculated using Eq. (6) are shown in Fig. 2.
The dose profile is shown with a dashed curve in order
to better illustrate the problem: a uniform distribution
of the physical dose along the SOBP yields a nonuniform
distribution of cell survival. A simple explanation of this
problem is that (as has been stated above) the radiation
damage with ions is not just the product of dose, but the
LET and physical consequences of high LET in particular.
Mathematically, the effect due to the σl(Sj) dependence
on LET. Largely, there two effects define σl(Sj). One is
the number reactive species including secondary electrons.
This number is roughly proportional to the LET. If this
would be the only effect, then, according to Eq. (4), the
average yield of lethal DNA lesions would be proportional
to the dose only. If the uniform physical dose is deliv-
ered using the corresponding choice of coefficients fj , as
the dashed line shows in Fig. 2, the yield would be uni-
form (as the solid line shows in Fig. 3). The other effect
is the effective spreading of the reactive species, discussed
in relation with the predicted shock waves [39,15,40] and
demonstrated in Ref. [30]. This effect is more complex,
but is linear in the first order with respect to LET. This
argument explains why this problem has not been solved
by the track structure community. Since all their radia-
tion damage estimates are based on the deposited energy
and the collective transport by the shock wave is missing,
the predicted damage is proportional to the dose while the
LET dependence is missing.
Now we can solve an inverse problem: aiming at a given
uniform survival probability, find the coefficients fj for ini-
tial ions’ fluences distribution. For that, we need to keep∑
j fjσl(Sj) constant along the SOBP and find the coeffi-
cients fj from this condition. Similarly to Eq.(8) we write:
σl(Se(x0)) = σl(S0(E0, x0))
σl(Se(x1)) = σl(S0(E0, x1)) + f1σl(S1(E0 −∆E, x1))
σl(Se(x2)) = σl(S0(E0, x2)) + f1σl(S1(E0 −∆E, x2))
+f2σl(S2(E0 − 2∆E, x2))
...
σl(Se(xN )) =
∑
fjσl(Sj(E0 −N∆E, xN )) ,(9)
Similarly, for each j, the coefficient fj is determined from
equation j. The results of application of this algorithm
are shown in Fig. 3; again, the dose profile is shown with
a dashed curve for guidance, while the solid line shows a
profile of the yield of lethal lesions. In addition to this, we
want to add, that the oxygen effect can also be added to
the calculation of σl(Sj) on the local basis. Then it may
also affect the choice of fjs. Thus, the problem has been
solved.
In conclusion, the problem of varying cell survival along
the SOBP has been investigated using the MSA. Its ori-
gin has been related to the physical effects such as prop-
agation of reactive species by collective flows induced by
ion-induced shock waves that take place at high LET. The
solution to this problem is suggested and it may lead to a
substantial improvement of treatment planning. The sug-
gested method calls for further investigations, especially
experimental. A thorough study of cell survival along the
SOBP is strongly desirable. Theoretically, a better depth-
dose curves should be used for practical applications, how-
ever, as it has been explained, the cause of the effect has
nothing to do with the shape of these curves.
The suggested algorithm can be implemented in novel
treatment planning and optimisation codes. Differences
in cells and conditions can be included in the existing
method. Manifestations of other biological phenomena,
such as DNA repair beyond linear effect [20], bystander
effect, etc. can be included empirically until a fundamen-
tal understanding is achieved.
Appendix: Calculation of σ(S
e
)
As is explained in the main text,
σ(Se) =
1
ns
dNc
dx
, (10)
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Fig. 3. The solid line shows the profile of dependence of
yield of lethal lesions in cells along the SOBP as a function of
distance on the distal end of the SOBP. The algorithm (9) has
been used. The dashed line shows the profile of the depth-dose
curve that produced the above result.
is the cross section of inducing a lethal damage in a cell
nucleus. Its calculation has been discussed in detail in
Refs. [15,20] and we are only briefly go over it.
The calculation starts with the determining a number
of secondary electrons incident on a target, defined as a
site on which a lethal damage can be induced. Lethality is
introduced as a criterion of minimal complexity/multipli-
city of lesions within a site that make it irreparable bi-
ologically. The number of lesions is proportional to the
number of incident electrons, while the latter is propor-
tional to LET. Then, the concentration of reactive species
multiplied by their effectiveness is introduced. Both the
number and effectiveness depend on the chemical proper-
ties of the medium that include the abundance of oxygen
(both increase with increasing concentration of oxygen).
The average number for multiply damage sites (per
target) containing clustered damage at a distance r from
the ion’s path is given by
Nc(r) = Ne(r) +Nr(r) = ΓeFe(r) + ΓrFr(r) , (11)
where the functions Ne(r) and Nr(r) define the average
number of lesions like SSBs, base damages, abasic states,
etc., induced by secondary electrons and other reactive
species (free radicals, pre-solvated and solvated electrons,
etc.), respectively. Fe(r) is the number of secondary elec-
trons incident in the target at a distance r from the ion’s
path. Fr(r) is that for other reactive species. Γe and Γr
are the probabilities of inducing simple lesions to a DNA
molecule by the corresponding species on impact.
The criterion of lethality described above is introduced
as follows. The probability of lethal damage, Pl(r), is given
by
Pl(r) = λ
∞∑
ν=3
N νc
ν!
exp [−Nc] . (12)
The sum starts from ν = 3, which makes the minimum
order of lesion complexity at a given site larger or equal to
three. The factor λ indicates that one of the simple lesions
is converted to a DSB. This implies that in the current
model the DSBs occur via SSB conversion; in principle,
other mechanisms can also be taken into account.
Then the cumulative effect of secondary electrons and
reactive species have to be integrated over the volume for a
given segment of ion’s trajectory. At this point, the radial
range to which the reactive species can propagate becomes
quite important. This range is determined by the strength
of the shock wave whose collective flow is mainly respon-
sible for the propagation of reactive species. According
to this, Nr(r) = Nrθ(R(Se) − r), where θ is a Heaviside
function. The integral,
dNl
dx
= ns
∫
∞
0
Pl(r)2pirdr = nsσl(Se) , (13)
where ns is the number density of sites, gives the number
of clustered damage sites per unit length of the ion’s tra-
jectory, defines σl. The number density of targets, ns, is
proportional to the ratio of base pairs accommodated in
the cell nucleus to the nuclear volume, ns ∼ Nbp/Vn [20].
Further detail of calculation of Fe(r), Γe, etc. can be
found in Ref. [15]. The latest on the study of R(Se) is in
Ref. [30].
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